Commercialization: Page 68

PharmaVoice Team/PharmaVoice

Showcases

Boomerang Pharmaceutical Communications 112 Main Rd., Bldg. 2 Ste. 6 Montville, NJ 07045 Phone: 973-265-8319 Fax: 973-265-8499 www.boomerangpharma.com Playful Name, Serious Results. Boomerang Pharmaceutical Communications is a global creative and results-driven, interactive ad agency. We define, ...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

External Experts: Optimal Engagement Strategies in a Digital Age

Organizations within the healthcare industry often work with external experts on an array of initiatives. These experts collaborate in a variety of ways, including working as advisory board members, investigators, media spokespeople, and speakers. Once a genuine need for expert engagement has bee...
By Jon Hudson Vice President • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Are You Properly Equipped to Execute Risk-Based Site Monitoring?

As the life-science industry focuses on moving toward a risk-based site monitoring approach where partial source document verification (SDV) is employed, it is critical that the clinical organization have the right tools and processes in place to efficiently execute such a strategy. As is typical...
By Ashwin Mundra • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Measuring ROI in Digital and Social: Five Metrics That Matter Now

Every successful digital and social plan has three complementary parts: the strategy, the marketing plan, and the optimization commitment. Leigh Householder Digital Strategist very conversation about digital and social marketing should start with these six words: What do you want to accomplish? ...
By Leigh Householder • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Achieving Digital Marketing Success

VIEW on E-SOLUTIONS Reaching Your Target Audience R.J. Lewis, President & CEO Your target audience is on the Internet, using e-mail, and connected via mobile in greater numbers than ever before. Yet the pharmaceutical industry’s digital media expenditures still come nowhere close to correlati...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

View on E-Solutions: In the E-Driver's Seat

Information Transformation In its report, Shaping the Future of Pharmaceutical R&D: Executing to a Vision of High Performance, Accenture noted that the leading-edge R&D groups are abandoning existing organizational barriers in favor of a networked, virtual, and flexible approach to R&...
By Carolyn Gretton • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Healthcare Reform and Comparative Effectiveness

We all know that R&D focus, pharmaceutical promotion, pricing, and reimbursement are all, or will be, critically affected by the biggest U.S. healthcare reform to occur in 40 years. The impact is going to be disruptive, but overall, experts says it will be a positive gain for the pharmaceutic...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

The Sales Force of the Future

Of all the factors that will influence how sales reps perform their jobs tomorrow, experts outline training, specialty roles, and social media as the top three that will most influence the size, strategies, and success of sales forces in the future. Training is Crucial. As new skill sets become ...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

To Twitter and Beyond

For several years there has been much debate regarding whether pharma companies should even use social media as a means to communicate with its consumers. Our experts project that social media will move beyond Twiiter and support many functions within marketing strategies, thus securing a permane...
By Robin Robinson • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Marketing: What Was Old Is New Again

Patients, ROI, an evolving landscape, and so on have been on the minds of marketers for years; but today success will lie in new solutions and approaches to overcome these chronic issues through innovative technologies and adaptive strategies. Patients Take Center Stage Our experts tell us that t...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

A More Conservative Regulatory Landscape

In the last few years, the FDA has come under strong criticism for the rate of adverse events, high-profile drug recalls, and contamination of both food and drug products. Agency officials have made steps to address drug safety and provide a more open and transparent regulatory environment. For t...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

The Crystal Ball

Dr. John Arrowsmith Scientific Director Thomson Reuters, which delivers critical information to leading decision makers in the financial, legal, tax and accounting, healthcare, science, and media markets. For more information, visit lifesciencesconsulting.thomsonreuters.com. 1. Outsourcing. There...
By PharmaVoice Team • Nov. 10, 2010
PharmaVoice Team/PharmaVoice

Talent Pool

Biopharmaceutical POOL Michael BAILEY Dr. Donna RADZIK Aveo Pharmaceuticals Bolsters Leadership Aveo Pharmaceuticals, a biopharmaceutical company focused on discovering, developing, and commercializing cancer therapeutics, has appointed Michael Bailey chief commercial officer. Mr. Bailey joins Av...
By PharmaVoice Team • Nov. 9, 2010
PharmaVoice Team/PharmaVoice

On the Calendar

November 18-19 2nd Annual VA * DoD * PHS Federal Pricing and Contracts for Bio/Pharmaceutical Companies Courtyard Philadelphia Downtown, Philadelphia PharmaVOICE subscribers receive $400 discount; register using keycode RGR396. Center for Business Intelligence, cbinet.com November 18-19 West Coa...
By PharmaVoice Team • Nov. 9, 2010
PharmaVoice Team/PharmaVoice

What's New

Ireland-based Firecrest has opened a facility in Princeton, N.J., that implements the company’s site performance management systems to help U.S.-based companies solve the challenges faced during clinical trial management and site performance. Firecrest’s products help investigators run complex tr...
By PharmaVoice Team • Nov. 9, 2010
PharmaVoice Team/PharmaVoice

PharmaTrax

Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Market Education Should Start Early in Oncology Drug Development Sidebar: Developing Thought Leaders Sales Call Volume Posts Slight Decline in First Half of 2010 Sidebar: Sales Calls for Top Pharma Companies Companies ...
By PharmaVoice Team • Nov. 9, 2010
PharmaVoice Team/PharmaVoice

This Revolution Won't be Televised

Marketers and regulators continue to grapple with what constitutes appropriate use of social media in life-sciences communications. Regardless of the outcome, analysts agree that the explosive growth and adoption of social media is bound to revolutionize pharma marketing strategies. In the las...
By PharmaVoice Team • Oct. 12, 2010
PharmaVoice Team/PharmaVoice

Get Comfortable, Everyone

So you’re launching a new drug into a semicrowded category, and you’ve got great data that’s played really well in market research. You’ve vetted everything from positioning to messaging to creative with your target. Things look good. Physicians say they’ll be “very likely" to prescribe your bran...
By PharmaVoice Team • Oct. 12, 2010
PharmaVoice Team/PharmaVoice

Increasing the Impact of Direct-to-Patient Programs

As brand teams create strategic plans for 2011, many will include programs that reach out to patients directly through tactics such as Websites, co-pay assistance cards, and patient resource kits. Direct-to-patient (DTP) programs make sense for brand teams who have overcome the first hurdle — get...
By PharmaVoice Team • Oct. 12, 2010
PharmaVoice Team/PharmaVoice

Charting the New Information Ecosystem: Creating an eKOL Map

Rima Nachshen SVP, Director of Client Services, Ogilvy CommonHealth, Interactive Marketing Brad Davidson, Ph.D. SVP, Management Supervisor, Ogilvy CommonHealth The elite KOL vies for influence with a teeming mass of rapidly evolving website producers, chatroom monitors and mavens, bloggers, p...
By PharmaVoice Team • Oct. 12, 2010
PharmaVoice Team/PharmaVoice

The Beauty of the Basics

John Wooden, the famous “winningest coach" of UCLA basketball, knew the beauty of the basics. At the beginning of every season he would spend the first two hours of practice teaching his star freshmen how to properly put on their shoes and socks. The socks were to be pulled tight without wrinkles...
By PharmaVoice Team • Oct. 12, 2010
PharmaVoice Team/PharmaVoice

E-Sampling is No Longer an "alternative" Solution

Drug sampling remains a critical and increasingly challenging aspect of pharmaceutical sales and marketing. Healthcare decision-makers count on office-based physicians distributing samples to enhance patient behavior. At the same time, pharmaceutical marketers frequently use samples to generate p...
By PharmaVoice Team • Oct. 12, 2010
PharmaVoice Team/PharmaVoice

The Crusade for Brand Relevance

I recently realized that I have a love-hate relationship with a few things in my life. Oreo Cookie Blizzards, reality TV, my iPad, my mobile phone, and my computer. I love them at the time of use or indulgence, but inevitably pay for them later in the form of calories, time wasting, or the feelin...
By PharmaVoice Team • Oct. 12, 2010
PharmaVoice Team/PharmaVoice

A Surround Sound Perspective on Comparative Effectiveness

As the industry waits for the FDA’s implementation plan for comparative effectiveness research, the senior executives of The Core Nation (Core-Create/Brandkarma/Alpha & Omega) offer a multifaceted perspective on the brand implications of this new regulatory mandate. Ken Kramer, Ph.D. Senior V...
By PharmaVoice Team • Oct. 12, 2010
PharmaVoice Team/PharmaVoice

What Patients Want

We spend the great part of our days at Catalina helping our clients communicate with their end customer, the patient who actually takes the drug they market. For some members of the brand team it’s a new and unique experience. Many have spent their time either focused on the health care provider ...
By PharmaVoice Team • Oct. 12, 2010